Related Experiment Videos
[7 years' experience with neonatal tetanus in Yucatan]
M Zaidi1, A Zamudio-Coutiño, J Cambranis-Puga
1Hospital General O'Horán, Mérida, Yucatán, México.
Boletin Medico Del Hospital Infantil De Mexico
|July 1, 1993
Summary
Neonatal tetanus (NT) treatment varies by severity. Severe NT (grades IV-V) with poor prognostic factors requires neuromuscular blockade (NB), while less severe cases can be managed with diazepam, improving survival rates.
Area of Science:
- Pediatrics
- Infectious Diseases
- Critical Care Medicine
Background:
- Neonatal tetanus (NT) is a significant cause of mortality in newborns.
- Identifying prognostic factors is crucial for selecting appropriate therapeutic strategies.
Purpose of the Study:
- To identify factors predicting poor prognosis in neonatal tetanus.
- To guide the selection of therapeutic regimens, including diazepam and neuromuscular blockade (NB).
Main Methods:
- Retrospective study of 46 patients with neonatal tetanus.
- Comparison of treatment outcomes between diazepam and pancuronium (NB).
- Analysis of prognostic factors such as apnea and age at admission.
Main Results:
- Diazepam was effective for NT grades II-III (0% mortality).
- For NT grades IV-V, diazepam had a 55% mortality rate, while NB had 100% mortality.
- Poor prognostic factors for diazepam treatment included apnea and age ≤ 7 days.
- Patients on NB survived longer but died from nosocomial infections.
Conclusions:
- NB is recommended for severe NT (grades IV-V) with poor prognostic factors.
- Diazepam may be suitable for severe NT without poor prognostic factors in resource-limited settings.
- Mild NT (grades I-III) can be effectively treated with diazepam alone.